Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +11.39%
#3 Meteora Meteora +11.20%
#4 Pump.fun Pump.fun +10.23%
#5 Unit Pump Unit Pump +10.23%
#6 eCash eCash +8.55%
#7 Cash Cat Cash Cat +8.41%
#8 OPENLOOT OPENLOOT +8.29%
#9 Glidr Glidr +7.60%
#10 Fake World Assets Fake World Assets +6.63%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Advicenne S.A. Advicenne S.A.

Advicenne S.A.

ALDVI
Rank in Stocks #28004
Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the... Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.
Share Price
$2.00
Last synced: 2026-08-19
Market Cap
$29.13M
Change (1 day)
0.24%
Change (1 year)
38.57%
Country
FR
Trade Advicenne S.A. (ALDVI)

Category

Healthcare
P/B ratio for Advicenne S.A. (ALDVI)
P/B ratio as of 2026 TTM: 0
According to Advicenne S.A. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Advicenne S.A. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH